NASDAQ:ESTA Establishment Labs Q3 2026 Earnings Date & Estimates $61.67 +1.06 (+1.75%) Closing price 04:00 PM EasternExtended Trading$61.63 -0.04 (-0.06%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Establishment Labs is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeBefore Market OpensConference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Establishment Labs in Q3 2026Establishment Labs is expected to post earnings of -$0.2624 per share on revenue of $66.79 million. In the same quarter a year earlier Establishment Labs reported -$0.38 per share on revenue of $53.78 million. Establishment Labs last reported on August 6, 2026, posting -$0.39 per share and missing the -$0.3368 consensus estimate. Establishment Labs has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.2624Expected Revenue$66.79 millionPrior-Year EPS-$0.38Prior-Year Revenue$53.78 millionExpected Revenue Growth+24.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.39 (Missed by -$0.0532)Last Quarter Revenue$67.54 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Establishment Labs Q3 2026 Earnings FAQ When does Establishment Labs report Q3 2026 earnings? Establishment Labs (NASDAQ:ESTA) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. What time is Establishment Labs' Q3 2026 earnings call? Establishment Labs' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Establishment Labs? Analysts expect Establishment Labs to post earnings of -$0.2624 per share for Q3 2026. How much revenue is Establishment Labs expected to report? The consensus revenue estimate for Establishment Labs is $66.79 million for Q3 2026. Establishment Labs Earnings HeadlinesCanaccord Genuity Sticks to Its Buy Rating for Establishment Labs Holdings (ESTA)October 8 at 8:12 PM | theglobeandmail.comEstablishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?October 7 at 3:43 AM | finance.yahoo.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 9 at 1:00 AM | Banyan Hill Publishing (Ad)Establishment Labs Holdings Inc. Receives Fda Approval for Expanded Range of Motiva Smoothsilk Round and Motiva Smoothsilk Ergonomix Breast ImplantsOctober 6 at 12:34 PM | marketscreener.comMEstablishment Labs Says US FDA Approves Additional Sizes of Motiva ImplantsOctober 5, 2026 | marketscreener.comMEstablishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®October 5, 2026 | finance.yahoo.comSee More Establishment Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Establishment Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Establishment Labs and other key companies, straight to your email. Email Address About Establishment LabsEstablishment Labs (NASDAQ:ESTA) (NASDAQ: ESTA) is a medical technology company focused on women’s health and breast aesthetics. The company develops, manufactures and markets medical devices intended for breast augmentation, reconstruction and related procedures. Its principal product portfolio includes Motiva breast implants, a line of silicone-gel implants designed for aesthetic and reconstructive applications, as well as tissue expanders and other products used in breast surgery. Establishment Labs also offers Mia Femtech, a technology and procedure platform designed to support a less invasive approach to breast augmentation. Founded in 2004, Establishment Labs is headquartered in Costa Rica and serves healthcare providers and patients in international markets. Its products have been distributed globally, with the company historically maintaining a presence across Europe, Latin America, Asia and other regions. The company was founded by Juan José Chacón-Quesada, who serves as its chief executive officer.View Establishment Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
